Skip to main content
. 2018 Nov 6;6(1):19–22. doi: 10.5152/eurjrheum.2018.18096

Table 2.

Characteristics of the eight patients with TST conversion

Patient Disease Sex Occupation Poverty Overcrowding DBT TB history Steroid use Use of Concomitant cDMARD Type of bDMARD Used Time of Chest X-Ray TST Conversion Isoniazid Treatment Active TB
1 PsA M Professional No No No No No No Adalimumab Normal 22 months Yes No
2 RA F Housewife No No No No No Yes etanercept Normal 8 months Yes No
3 RA F Unemployed No No No No No Yes etanercept Normal 12 months Yes No
4 PsA M Trader No Yes No No No Yes adalimumab Normal 7 months Yes No
5 RA F Trader No No No No Yes Yes etanercept Normal 9 meses Yes No
6 RA M Trader No No No No No No tocilizumab Normal 17 meses Yes No
7 RA M Construction worker No No Yes Yes Yes Yes adalimumab Abnormal 20 meses TB treatment Yes
8 PsA M Trader No No No Yes No Yes etanercept Normal 8 meses Yes No

DBT: diabetes, TB: tuberculosis, DMARD: disease-modifying anti-rheumatic drug, RA: rheumatoid arthritis, PsA: psoriatic arthritis, SD: standard deviation, Steroid use: prednisone >10 mg/day